Murayama T
Department of Pediatrics, Tokyo Medical College.
Kansenshogaku Zasshi. 1991 Mar;65(3):336-43. doi: 10.11150/kansenshogakuzasshi1970.65.336.
I developed on immunoblotting assay for the detection of antibodies to mumps virus components, using purified mumps virus propagated in Vero cell cultures, and investigated the presence of antibodies after vaccination in comparison with enzyme linked immunosorbent assay (ELISA). In the immunoblotting assay, antibodies to hemagglutinin-neuraminidase (HN) and fusion (F) protein were detected two weeks after vaccination with live mumps vaccine, in accordance with the presence of ELISA antibodies. All serum samples positive in ELISA showed positive in immunoblotting, and two out of nine samples negative in ELISA after vaccination were positive in immunoblotting. Thus, the immunoblotting method is considered to be more sensitive than ELISA for the detection of antibodies to mumps virus.
我开发了一种免疫印迹检测法,用于检测针对腮腺炎病毒成分的抗体,该方法使用在Vero细胞培养物中繁殖的纯化腮腺炎病毒,并与酶联免疫吸附测定法(ELISA)比较,研究了疫苗接种后抗体的存在情况。在免疫印迹检测法中,接种减毒活腮腺炎疫苗两周后可检测到针对血凝素神经氨酸酶(HN)和融合(F)蛋白的抗体,这与ELISA抗体的存在情况一致。所有ELISA检测呈阳性的血清样本在免疫印迹检测中也呈阳性,接种疫苗后ELISA检测呈阴性的9个样本中有2个在免疫印迹检测中呈阳性。因此,免疫印迹法在检测腮腺炎病毒抗体方面被认为比ELISA更灵敏。